News
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that the United States (U.S.) ...
2d
GlobalData on MSNNeuspera secures FDA approval for urinary incontinence implantableThe US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for ...
The FDA has approved Gilead Sciences' lenacapavir, sold under the name Yeztugo, as a twice-yearly injection for preventing ...
4d
India Today on MSNLenacapavir becomes first FDA-approved HIV preventive drug: All about itThe US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...
3d
Zacks Investment Research on MSNFDA Approves Gilead's Twice-Yearly Shot for HIV PreventionGilead Sciences, Inc. GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the ...
The U.S. FDA approved Gilead Sciences' lenacapavir, under the brand name Yeztugo, for HIV prevention. This twice-yearly ...
4d
Smithsonian Magazine on MSNTexas Will Invest $50 Million in Ibogaine Research, Testing the Psychedelic Drug’s Medical PotentialThe state's new law marks one of the largest government investments into psychedelics to date, with advocates citing the drug ...
While PrEP tablets are already prescribed around the world to prevent people from contracting HIV, experts in the US hope a newly approved jab could improve rates of protection.
2d
Zacks Investment Research on MSNSanofi & Regeneron's Dupixent Gets FDA Nod for Bullous PemphigoidSanofi SNY and its partner, Regeneron REGN, announced that the FDA has approved their blockbuster medicine, Dupixent ...
Agappe Corporate Office COCHIN, KERALA, INDIA, June 20, 2025 /EINPresswire / -- Agappe Diagnostics Ltd is poised to pioneer a transformative c ...
TEL AVIV, Israel, June 18, 2025 /PRNewswire/ -- MedHub-AI, a global leader in AI-powered cardiovascular diagnostics, announced today that the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results